|Podcasts|April 29, 2021
Episode 81: Cancer Research Amid COVID
Author(s)Elaine Quilici
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer research going throughout the pandemic.
Advertisement
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, talks about the challenges and silver linings of continuing cancer research during the pandemic.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
3
Taking Advantage of ‘Hidden Gem’ Talent Hubs
4
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
5